Go offline with the Player FM app!
Immunotherapy for early-stage, resectable NSCLC
Manage episode 428169015 series 3389426
Prof. Heather Wakelee discusses the use of immune checkpoint inhibitors for early-stage, resectable NSCLC, considering the most recent data on pre-, post- and peri-operative immunotherapy and their impact on clinical practice.
The expert
- Prof. Heather A Wakelee – Stanford University, CA, USA
This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Merck & Co., Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
https://touchrespiratoryime.org/io-early-stage-nsclc/
102 episodes
Manage episode 428169015 series 3389426
Prof. Heather Wakelee discusses the use of immune checkpoint inhibitors for early-stage, resectable NSCLC, considering the most recent data on pre-, post- and peri-operative immunotherapy and their impact on clinical practice.
The expert
- Prof. Heather A Wakelee – Stanford University, CA, USA
This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Merck & Co., Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
https://touchrespiratoryime.org/io-early-stage-nsclc/
102 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.